{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:12:51Z","timestamp":1789056771783,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10047-026-01565-8","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:49:49Z","timestamp":1782859789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a novel anticoagulant and fibrinolytic management monitoring method during extracorporeal circulation using clot-fibrinolysis waveform analysis: the effects of anticoagulants on coagulation and fibrinolysis functions"],"prefix":"10.1007","volume":"29","author":[{"given":"Sadanori","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Soyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"6","key":"1565_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.athoracsur.2006.06.072","volume":"82","author":"L Henry Edmunds Jr","year":"2006","unstructured":"Henry Edmunds L Jr, Robert W, Colman. Thrombin during cardiopulmonary bypass. Ann Thorac Surg. 2006;82(6):2315\u201322.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"1565_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","volume":"20","author":"JE Millar","year":"2016","unstructured":"Millar JE, Fanning JP, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20(1):387.","journal-title":"Crit Care"},{"key":"1565_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fmed.2018.00352","volume":"5","author":"AJ Doyle","year":"2018","unstructured":"Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"1565_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/jth.13957","volume":"16","author":"C Longstaff","year":"2018","unstructured":"C Longstaff. Measuring fibrinolysis: from research to routine diagnostic assays. J Thromb Haemost. 2018;16(4):652\u201362.","journal-title":"J Thromb Haemost"},{"key":"1565_CR5","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1513\/AnnalsATS.201605-364SR","volume":"13","author":"MC Sklar","year":"2016","unstructured":"Sklar MC, Sy E, et al. Anticoagulation practices during venovenous extracorporeal membrane oxygenation for respiratory failure. A systematic review. Ann Am Thorac Soc. 2016;13:2242\u201350.","journal-title":"Ann Am Thorac Soc"},{"key":"1565_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.athoracsur.2015.07.046","volume":"101","author":"M Mazzeffi","year":"2016","unstructured":"Mazzeffi M, Greenwood J, Tanaka K, et al. Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg. 2016;101:682\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1565_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0037-1606179","volume":"44","author":"J Thomas","year":"2018","unstructured":"Thomas J, Kostousov V, et al. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost. 2018;44:20\u20139.","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"1565_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1525-1594.2011.01374.x","volume":"35","author":"T Goto","year":"2011","unstructured":"Goto T, Suzuki Y, et al. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with respiratory and heart failure: review of our experience. Artif Organs. 2011;35(11):1002\u20139.","journal-title":"Artif Organs"},{"issue":"6","key":"1565_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s13054-014-0675-x","volume":"18","author":"R-G Han Chen","year":"2014","unstructured":"Han Chen R-G. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review. Crit Care. 2014;18(6):675.","journal-title":"Crit Care"},{"key":"1565_CR10","doi-asserted-by":"crossref","unstructured":"Jamshid Amanzadeh 1, Reilly RF Jr. Anticoagulation and continuous renal replacement therapy. Semin Dial. 2006 Jul-Aug; 19 (4): 311-6.","DOI":"10.1111\/j.1525-139X.2006.00178.x"},{"issue":"9","key":"1565_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","volume":"33","author":"S Uchino","year":"2007","unstructured":"Uchino S, Bellomo R, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33(9):1563\u201370.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1565_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00281-011-0283-7","volume":"34","author":"T Marcel Levi","year":"2011","unstructured":"Marcel Levi T, van der Poll, et al. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol. 2011;34(1):167\u201379.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"1565_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/bjh.16111","volume":"187","author":"K Nogami","year":"2019","unstructured":"Nogami K, Matsumoto T, et al. A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders. Br J Haematol. 2019;187(4):518\u201329.","journal-title":"Br J Haematol"},{"key":"1565_CR14","first-page":"1568333","volume":"12","author":"H Ruishan Yao","year":"2025","unstructured":"Ruishan Yao H, Huang, et al. Anticoagulant regimens for different therapeutic plasma exchange modes. Front Med (Lausanne). 2025;12:1568333.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"1565_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3346\/jkms.2011.26.7.945","volume":"26","author":"SJ Han","year":"2011","unstructured":"Han SJ, Kim HS, et al. Use of nafamostat mesilate as an anticoagulant during extracorporeal membrane oxygenation. J Korean Med Sci. 2011;26(7):945\u201350.","journal-title":"J Korean Med Sci"},{"issue":"12","key":"1565_CR16","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/aor.14276","volume":"46","author":"F Sanfilippo","year":"2022","unstructured":"Sanfilippo F, Marika Curro J, et al. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: a systematic review. Artif Organs. 2022;46(12):2371\u201381.","journal-title":"Artif Organs"},{"key":"1565_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijcard.2022.07.022","volume":"366","author":"Y Lang","year":"2022","unstructured":"Lang Y, Zheng Y, et al. Anticoagulation with nafamostat mesilate during extracorporeal life support. Int J Cardiol. 2022;366:71\u20139.","journal-title":"Int J Cardiol"},{"key":"1565_CR18","doi-asserted-by":"crossref","unstructured":"Matsumoto T, Tsujii N et al. Clarification of fibrin generation and degradation reaction processes of clot-fibrinolysis waveform in hemorrhagic disorders. PLoS ONE. 2025;20(8):e0320111.","DOI":"10.1371\/journal.pone.0320111"},{"issue":"5","key":"1565_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00540-012-1402-x","volume":"26","author":"S Takeda","year":"2012","unstructured":"Takeda S, Kotani T, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) severe respiratory failure in Japan. J Anesth. 2012;26(5):650\u20137.","journal-title":"J Anesth"},{"key":"1565_CR20","doi-asserted-by":"crossref","unstructured":"Wassia A, Khaja O, Bilen et al. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol 2010;134(6):950\u2013954.","DOI":"10.1309\/AJCPGVD62LKKVDLH"},{"issue":"2","key":"1565_CR21","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1097\/PCC.0000000000000028","volume":"15","author":"A Liveris","year":"2014","unstructured":"Liveris A, Ricardo A, Bello, et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014;15(2):e72\u20139.","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"1565_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/0885066618776937","volume":"35","author":"C Delamas","year":"2020","unstructured":"Delamas C, Jacquemin A, et al. Anticoagulation monitoring under ECMO support: a comparative study between the activated coagulation time and the Anti-Xa activity assay. J Intensive Care Med. 2020;35(7):679\u201386.","journal-title":"J Intensive Care Med"},{"issue":"1","key":"1565_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12959-023-00452-z","volume":"21","author":"SZ Shirejini","year":"2023","unstructured":"Shirejini SZ, Carberry J, et al. Current and future strategies to monitor and manage coagulation in ECMO patients. Thromb J. 2023;21(1):11.","journal-title":"Thromb J"},{"key":"1565_CR24","doi-asserted-by":"crossref","unstructured":"Leon Rosebery M, Miller et al. A retrospective validation of ROTEM algorithms for detecting hyperfibrinolysis demonstrates poor agreement for prediction of in-hospital mortality and transfusion requirement in a general, non-cardiac, surgical population. Thromb Res. 2023;229:170\u2013177.","DOI":"10.1016\/j.thromres.2023.07.009"},{"key":"1565_CR25","doi-asserted-by":"crossref","unstructured":"Onishi T, Shimonishi N et al. The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19. Int J Hematol. 2022;115(6):826\u201337.","DOI":"10.1007\/s12185-022-03308-w"},{"key":"1565_CR26","doi-asserted-by":"crossref","unstructured":"Oka S, Wakui M et al. Application of clot fibrinolysis waveform analysis to assessment of in vitro effects of direct oral anticoagulants on fibrinolysis. Int J Lab Hematol. 2022;42:292\u20138.","DOI":"10.1111\/ijlh.13168"},{"issue":"3","key":"1565_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ijlh.14437","volume":"47","author":"A Yoshioka","year":"2025","unstructured":"Yoshioka A, Shimomura D, et al. Evaluation of coagulation and fibrinolysis mechanisms in deep vein thrombosis using clot-fibrinolysis waveform analysis. Int J Lab Hematol. 2025;47(3):510\u20139.","journal-title":"Int J Lab Hematol"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-026-01565-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-026-01565-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-026-01565-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:03:22Z","timestamp":1789056202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-026-01565-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s10047-026-01565-8","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}